Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
44.48
-0.28 (-0.63%)
Oct 15, 2025, 4:00 PM EDT
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$773,189
Profits / Employee
$114,831
Market Cap
305.41B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 103,249 | -356 | -0.34% |
Dec 31, 2023 | 103,605 | -8 | -0.01% |
Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
Dec 31, 2021 | 100,920 | -545 | -0.54% |
Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Glass House Brands | 374 |
Elite Pharmaceuticals | 68 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Jushi Holdings | 1,234 |
Nuo Therapeutics | 9 |
Roche Holding AG News
- 12 hours ago - Pharma M&A Activity Picks Up Pace: What Does It Signal for 2026? - Nasdaq
- 1 day ago - Wall Street Breakfast Podcast: Papa John's Delivers A Hot Slice - Seeking Alpha
- 2 days ago - Eli Lilly (LLY) and Roche's Blood Test for Alzheimer's Gets FDA Nod - GuruFocus
- 2 days ago - Roche, Eli Lilly Alzheimer's blood diagnostic test wins FDA approval - Seeking Alpha
- 2 days ago - Roche Holding's Blood-Based Alzheimer's Test Wins US FDA Approval - Nasdaq
- 2 days ago - Roche, Lilly's blood test for Alzheimer's diagnosis gets US approval - Reuters
- 2 days ago - Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology - PRNewsWire
- 2 days ago - Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across Multiple Tumor Types - Business Wire